Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05918887 · ClinicalTrials.gov registry record · NA
Feasibility and Acceptability of Switching to E-cigarettes Among Cigarette Smokers Engaged in SUD Treatment
A NA study of Tobacco Dependence Caused by Cigarettes, sponsored by University of Nevada, Reno.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT05918887 is a NA study of Tobacco Dependence Caused by Cigarettes that has completed, run by University of Nevada, Reno. The registered enrollment target is 31 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05918887, a NA study of Tobacco Dependence Caused by Cigarettes, has completed, sponsored by University of Nevada, Reno.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the proposed study is to examine the feasibility of integrating a smoking harm reduction program featuring provision of e-cigarettes and tailored instructions to switch into an existing substance use disorder treatment program. This longitudinal study includes three weeks of micro-surveys delivered via text messages to evaluate the intervention's feasibility and acceptability, gather initial effectiveness data, and understand participants' lived experience of smoking and vaping while engaged in substance use disorder treatment.
Conditions Studied
Interventions
- DEVICE NJOY ACE commercial e-cigarette
Study Locations (1)
Nevada
- University of Nevada, Reno - Reno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2024-06-18 |
| Est. Completion | 2024-09-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05918887
The ClinicalTrials.gov registry entry for NCT05918887 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nevada, Reno, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tobacco Dependence Caused by Cigarettes appearing as the primary indexed condition, and to 1 intervention - of which NJOY ACE commercial e-cigarette is the first listed.
NCT05918887 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.
Frequently Asked Questions
What is clinical trial NCT05918887 about?
NCT05918887 is a clinical study titled "Feasibility and Acceptability of Switching to E-cigarettes Among Cigarette Smokers Engaged in SUD Treatment". The purpose of the proposed study is to examine the feasibility of integrating a smoking harm reduction program featuring provision of e-cigarettes and tailored instructions to switch into an existing substance use disorder treatment program. This longitudinal study includes three weeks of micro-sur...
What is the current status of trial NCT05918887?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2024-06-18. Estimated completion is 2024-09-13.
What conditions does trial NCT05918887 study?
This clinical trial studies the following conditions: Tobacco Dependence Caused by Cigarettes.
What interventions are being tested in trial NCT05918887?
The interventions under investigation include: NJOY ACE commercial e-cigarette (DEVICE).
Who is sponsoring clinical trial NCT05918887?
This trial is sponsored by University of Nevada, Reno, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05918887 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Dependence Caused by Cigarettes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.